Vincristine Sulfate Injection is indicated in acute leukemia. Vincristine Sulfate Injection has also been shown to be useful in combination with other oncolytic agents in Hodgkin's disease, non–Hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms' tumor.
From the U.S. FDA-approved label for Vincristine. Full label: DailyMed.
Vincristine Sulfate Injection is indicated in acute leukemia. Vincristine Sulfate Injection has also been shown to be useful in combination with other oncolytic agents in Hodgkin's disease, non–Hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms' tumor.
From the U.S. FDA-approved label for Vincristine. Full label: DailyMed.
This preparation is for intravenous use only (see WARNINGS ). Neurotoxicity appears to be dose related. Extreme care must be used in calculating and administering the dose of Vincristine Sulfate Injection since overdosage may have a very serious or fatal outcome.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Patients with the demyelinating form of Charcot–Marie–Tooth syndrome should not be given Vincristine Sulfate Injection. Careful attention should be given to those conditions listed under WARNINGS and PRECAUTIONS.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
This preparation is for intravenous use only. It should be administered by individuals experienced in the administration of Vincristine Sulfate Injection. The intrathecal administration of Vincristine Sulfate Injection usually results in death. To reduce the potential for fatal medication errors due to incorrect route of administration, Vincristine Sulfate Injection should be diluted in a flexible plastic container and prominently labeled as indicated "FOR INTRAVENOUS USE ONLY – FATAL IF GIVEN BY OTHER ROUTES." See OVERDOSAGE section for the treatment of patients given intrathecal Vincristine Sulfate Injection.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
Prior to the use of this drug, patients and/or their parents/guardian should be advised of the possibility of untoward symptoms. In general, adverse reactions are reversible and are related to dosage. The most common adverse reaction is hair loss; the most troublesome adverse reactions are neuromuscular in origin.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
15 products from 12 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Alcrist 1mg Injection | Vincristine (1mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| B Cristine 1mg Injection | Vincristine (1mg) | Health Biotech Limited | vial of 1 Injection |
| Biocristin 1mg Injection | Vincristine (1mg) | Biochem Pharmaceutical Industries | vial of 1 Injection |
| Biocristin AQ 1mg Injection | Vincristine (1mg) | Biochem Pharmaceutical Industries | vial of 1 ml Injection |
| Cytocristin 1mg Injection | Vincristine (1mg) | Cipla Ltd | vial of 1 ml Injection |
| Cytocristin 2mg Injection | Vincristine (2mg) | Cipla Ltd | vial of 2 ml Injection |
| Ivin 1mg Injection | Vincristine (1mg) | Vhb Life Sciences Inc | vial of 1 ml Injection |
| Oncocristin AQ 1mg Injection | Vincristine (1mg) | Sun Pharmaceutical Industries Ltd | vial of 1 ml Injection |
| Onvinc 1mg Injection | Vincristine (1mg) | Neon Laboratories Ltd | vial of 1 Injection |
| Vcad 1mg Injection | Vincristine (1mg) | Cadila Pharmaceuticals Ltd | vial of 1 Injection |
| Vincreta 1mg Injection | Vincristine (1mg) | Metta Life Sciences Private Limited | vial of 1 Injection |
| Vincryst 1mg Injection | Vincristine (1mg) | Chandra Bhagat Pharma Pvt Ltd | vial of 1 ml Injection |
| Vinlon 1mg Injection | Vincristine (1mg) | Celon Laboratories Ltd | vial of 1 ml Injection |
| Vinrosa 1mg Injection | Vincristine (1mg) | Naprod Life Sciences | vial of 1 ml Injection |
| Vinstin 1mg Injection | Vincristine (1mg) | Vhb Life Sciences Inc | vial of 1 Injection |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
This product should be refrigerated between 2°C–8°C (36°F–46°F). Discard unused solution. Protect from light. Store Upright.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
